Minocycline Hydrochloride

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

24 Suppliers, 16 USDMF, 6 CEP/COS, 3 JDMF, 2 KDMF, 15 NDC API, 10 Listed Suppliers

DEVELOPMENTS

45 Drug(s) in Development

45 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

176 Dossiers, 137 FDA Orange Book, 5 Europe, 7 Canada, 2 Australia, 6 South Africa, 19 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - EQ 100MG BASE/VIAL, CAPSULE;ORAL - EQ 100MG BASE, CAPSULE;ORAL - EQ 50MG BASE, CAPSULE;ORAL - EQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 105MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 115MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 135MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 55MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 65MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 80MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 35 Kerry, 27 BASF, 19 Roquette, 14 Seppic, 14 Microlex e.U, 11 Sigachi Industries, 10 Corel Pharma Chem, 10 Gangwal Chemicals, 9 Gangwal Healthcare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 Nanjing Well Pharmaceutical, 6 Lonza Capsugel, 6 DFE Pharma, 5 SPI Pharma, 5 Actylis, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 Ideal Cures Pvt Ltd, 4 ACG Worldwide, 4 Prachin Chemical, 4 Pharmatrans-Sanaq, 3 Kima Chemical, 3 Vasa Pharmachem, 3 Boai NKY Pharmaceuticals Ltd, 3 Ingredion Pharma Solutions, 2 Jai Radhe Sales, 2 The Dow Chemical Company, 2 Qualicaps, 2 Seqens, 2 Finar, 2 Nomisma Healthcare, 2 Ulanqab Kema New Material, 1 Aeon Procare, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 NEWEDGE Overseas, 1 DKSH, 1 Chynops Pharma, 1 Clariant, 1 Alcedo Pharmachem, 1 Minakem, 1 Vertellus, 1 Nanjing Bold Chemical

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders, 50 Coating Systems & Additives, 31 Direct Compression, 30 Controlled & Modified Release, 27 Lubricants & Glidants, 24 Disintegrants & Superdisintegrants, 24 Solubilizers, 23 Thickeners and Stabilizers, 22 Granulation, 19 Film Formers & Plasticizers, 17 Topical, 13 Co-Processed Excipients, 13 Parenteral, 10 Taste Masking, 9 Empty Capsules, 8 Chewable & Orodispersible Aids, 6 API Stability Enhancers, 6 Emulsifying Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Rheology Modifiers, 2 Coloring Agents

GLOBAL SALES INFORMATION

45 US Medicaid Prescriptions, 23 Finished Drug Prices

MARKET PLACE

31 APIs, 2 DOSSIERS // FDF

PATENTS

81 US Patents, 3 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 2 EDQM Standards, 1 USP Standards, 2 Other Ref. Standards

DIGITAL CONTENT

3 Data Compilation & Company Tracker #PharmaFlow, 69 News

Annual Sales of Minocycline Hydrochloride reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Minocycline Hydrochloride

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

24 Suppliers

16 USDMF

6 CEP/COS

3 JDMF

2 KDMF

15 NDC API

10 Listed Suppliers

DEVELOPMENTS

45 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

176 Dossiers

137 FDA Orange Book

5 Europe

7 Canada

2 Australia

6 South Africa

19 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - EQ 100MG BASE/VIAL

CAPSULE;ORAL - EQ 100MG BASE

CAPSULE;ORAL - EQ 50MG BASE

CAPSULE;ORAL - EQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - EQ 105MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 115MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 135MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - EQ 55MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 65MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 80MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

35 Kerry

27 BASF

19 Roquette

14 Seppic

14 Microlex e.U

11 Sigachi Industries

10 Corel Pharma Chem

10 Gangwal Chemicals

9 Gangwal Healthcare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Nanjing Well Pharmaceutical

6 Lonza Capsugel

6 DFE Pharma

5 SPI Pharma

5 Actylis

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 Ideal Cures Pvt Ltd

4 ACG Worldwide

4 Prachin Chemical

4 Pharmatrans-Sanaq

3 Kima Chemical

3 Vasa Pharmachem

3 Boai NKY Pharmaceuticals Ltd

3 Ingredion Pharma Solutions

2 Jai Radhe Sales

2 The Dow Chemical Company

2 Qualicaps

2 Seqens

2 Finar

2 Nomisma Healthcare

2 Ulanqab Kema New Material

1 Aeon Procare

1 Qianhao Chemical (Hebei) Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 NEWEDGE Overseas

CAPSULE;ORAL - EQ 75MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - EQ 135MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - EQ 45MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - EQ 90MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons